Cerebral Iron Deposition in Neurodegeneration

• Published in: Biomolecules (Basel, Switzerland) Switzerland), 2022-05, Vol.12 (5), p.714
• Main Authors: Dusek, Petr, Hofer, Tim, Alexander, Jan, Roos, Per M, Aaseth, Jan O
• Format: Article
• Language: English
• Subjects: Age; Aging; Alzheimer's disease; Amyotrophic lateral sclerosis; Astrocytes; Blood-brain barrier; Brain; Brain - pathology; chelation; Dopamine; Ferroptosis; Globus pallidus; Humans; Inflammation; Iron; Iron - pharmacology; iron accumulation; Iron Metabolism Disorders - pathology; Lipid peroxidation; Lipids; Macrophages; Magnetic resonance imaging; Medicin och hälsovetenskap; Microglia; Movement disorders; MRI; Multiple sclerosis; NBIA; Neuroaxonal Dystrophies - pathology; Neurodegeneration; Neurodegenerative diseases; Neurodegenerative Diseases - pathology; Neuroimaging; Neurons; Parkinson's disease; Proteins; Putamen; Reactive oxygen species; Review; Siderosis; Substantia grisea; Wilson's disease
• ISSN: 2218-273X; 2218-273X
• DOI: 10.3390/biom12050714

Disruption of cerebral iron regulation appears to have a role in aging and in the pathogenesis of various neurodegenerative disorders. Possible unfavorable impacts of iron accumulation include reactive oxygen species generation, induction of ferroptosis, and acceleration of inflammatory changes. Whole-brain iron-sensitive magnetic resonance imaging (MRI) techniques allow the examination of macroscopic patterns of brain iron deposits in vivo, while modern analytical methods ex vivo enable the determination of metal-specific content inside individual cell-types, sometimes also within specific cellular compartments. The present review summarizes the whole brain, cellular, and subcellular patterns of iron accumulation in neurodegenerative diseases of genetic and sporadic origin. We also provide an update on mechanisms, biomarkers, and effects of brain iron accumulation in these disorders, focusing on recent publications. In Parkinson's disease, Friedreich's disease, and several disorders within the neurodegeneration with brain iron accumulation group, there is a focal siderosis, typically in regions with the most pronounced neuropathological changes. The second group of disorders including multiple sclerosis, Alzheimer's disease, and amyotrophic lateral sclerosis shows iron accumulation in the globus pallidus, caudate, and putamen, and in specific cortical regions. Yet, other disorders such as aceruloplasminemia, neuroferritinopathy, or Wilson disease manifest with diffuse iron accumulation in the deep gray matter in a pattern comparable to or even more extensive than that observed during normal aging. On the microscopic level, brain iron deposits are present mostly in dystrophic microglia variably accompanied by iron-laden macrophages and in astrocytes, implicating a role of inflammatory changes and blood-brain barrier disturbance in iron accumulation. Options and potential benefits of iron reducing strategies in neurodegeneration are discussed. Future research investigating whether genetic predispositions play a role in brain Fe accumulation is necessary. If confirmed, the prevention of further brain Fe uptake in individuals at risk may be key for preventing neurodegenerative disorders.